Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

Qingqing Ding; Weiya Xia; Jaw-Ching Liu; Jer-Yen Yang; Dung‐Fang Lee; Jiahong Xia; Geoffrey Bartholomeusz; Yan Li; Yong Pan; Zheng Li; Ralf C. Bargou; Jun Qin; Chien‐Chen Lai; Fuu‐Jen Tsai; Chang‐Hai Tsai; Mien‐Chie Hung

doi:10.1016/j.molcel.2005.06.009

Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-Catenin

Qingqing Ding(The University of Texas MD Anderson Cancer Center), Weiya Xia(The University of Texas MD Anderson Cancer Center), Jaw-Ching Liu(The University of Texas MD Anderson Cancer Center), Jer-Yen Yang(The University of Texas MD Anderson Cancer Center), Dung‐Fang Lee(The University of Texas MD Anderson Cancer Center), Jiahong Xia(Union Hospital), Geoffrey Bartholomeusz(The University of Texas MD Anderson Cancer Center), Yan Li(The University of Texas MD Anderson Cancer Center), Yong Pan(The University of Texas MD Anderson Cancer Center), Zheng Li(The University of Texas MD Anderson Cancer Center), Ralf C. Bargou(Max Delbrück Center), Jun Qin(Baylor College of Medicine), Chien‐Chen Lai(China Medical University), Fuu‐Jen Tsai(China Medical University), Chang‐Hai Tsai(China Medical University), Mien‐Chie Hung(The University of Texas MD Anderson Cancer Center)

Molecular Cell

July 1, 2005

10.1016/j.molcel.2005.06.009

Cited by 597Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis